Literature DB >> 23452262

A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years.

Richard T Bryan1, Maurice P Zeegers, Eline H van Roekel, Deborah Bird, Margaret R Grant, Janet A Dunn, Sarah Bathers, Gulnaz Iqbal, Humera S Khan, Stuart I Collins, Andrew Howman, Nayneeta S Deshmukh, Nicholas D James, Kar Keung Cheng, D Michael A Wallace.   

Abstract

OBJECTIVES: To compare patient and tumour characteristics at presentation from two large bladder cancer cohorts, with recruitment separated by 15-20 years To identify significant differences in the West Midlands' urothelial cancer of the bladder (UCB) population during this period. PATIENTS AND METHODS: Data were collected prospectively from 1478 patients newly diagnosed with UCB in the West Midlands from January 1991 to June 1992 (Cohort 1), and from 1168 patients newly diagnosed with UBC within the same region from December 2005 to April 2011 (Cohort 2). Gender, age, smoking history, and tumour grade, stage, type, multiplicity and size at presentation were compared using a Pearson chi-square test or Cochran-Armitage trend test, as appropriate. RESULT: Cohort 2 had a higher proportion of male patients (P = 0.021), elderly patients (P < 0.001), grade 3 tumours (P < 0.001), Ta/T1 tumours (P = 0.008), multiple tumours (P < 0.001), and tumours of ≤2 cm in diameter (P < 0.001).
CONCLUSIONS: There were significant differences between the cohorts. These differences are potentially explained by an ageing population, changes in grading practices, improved awareness of important symptoms, improved cystoscopic technology, and reductions in treatment delays. Regional cohorts remain important for identifying changes in tumour and patient characteristics that may influence disease management in the UK and beyond.
© 2013 BJU International.

Entities:  

Mesh:

Year:  2013        PMID: 23452262     DOI: 10.1111/bju.12032

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours.

Authors:  V A During; G M Sole; A K Jha; J A Anderson; R T Bryan
Journal:  Ann R Coll Surg Engl       Date:  2016-08-09       Impact factor: 1.891

Review 2.  Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.

Authors:  Richard T Bryan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

3.  Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.

Authors:  Alexander C Dowell; Ellen Cobby; Kaisheng Wen; Adam J Devall; Vinnie During; Jane Anderson; Nicholas D James; Kar K Cheng; Maurice P Zeegers; Richard T Bryan; Graham S Taylor
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

4.  The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.

Authors:  Frits H M van Osch; Sylvia H J Jochems; Raoul C Reulen; Sarah J Pirrie; Duncan Nekeman; Anke Wesselius; Nicholas D James; D Michael A Wallace; K K Cheng; Frederik J van Schooten; Richard T Bryan; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2018-05-30       Impact factor: 2.506

5.  Patients choose certainty over burden in bladder cancer surveillance.

Authors:  Frits H M van Osch; Duncan Nekeman; Neil K Aaronson; Lucinda J Billingham; Nicholas D James; K K Cheng; Richard T Bryan; Maurice P Zeegers
Journal:  World J Urol       Date:  2019-03-23       Impact factor: 4.226

6.  Evaluation of Hematuria in a Large Public Health Care System.

Authors:  Rashed Ghandour; Yuval Freifeld; Nirmish Singla; Yair Lotan
Journal:  Bladder Cancer       Date:  2019-08-16

7.  Health-related quality of life around the time of diagnosis in patients with bladder cancer.

Authors:  Evan Yi-Wen Yu; Duncan Nekeman; Lucinda J Billingham; Nicholas D James; K K Cheng; Richard T Bryan; Anke Wesselius; Maurice P Zeegers
Journal:  BJU Int       Date:  2019-06-07       Impact factor: 5.588

8.  Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer: A Pooled Analysis of 15 Case-Control Studies.

Authors:  Frits H M van Osch; Jelle Vlaanderen; Sylvia H J Jochems; Cristina Bosetti; Jerry Polesel; Stefano Porru; Angela Carta; Klaus Golka; Xuejuan Jiang; Mariana C Stern; Wei-De Zhong; Eliane Kellen; Hermann Pohlabeln; Li Tang; James Marshall; Gunnar Steineck; Margaret R Karagas; Kenneth C Johnson; Zuo-Feng Zhang; Jack A Taylor; Carlo La Vecchia; Richard T Bryan; Frederik J van Schooten; Anke Wesselius; Maurice P Zeegers
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

Review 9.  Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Authors:  Nada Humayun-Zakaria; Douglas G Ward; Roland Arnold; Richard T Bryan
Journal:  Transl Androl Urol       Date:  2021-06

Review 10.  Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.

Authors:  Nada Humayun-Zakaria; Roland Arnold; Anshita Goel; Douglas Ward; Stuart Savill; Richard T Bryan
Journal:  Int J Mol Sci       Date:  2019-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.